← Back to Search

Proactive Telephone Counseling from VA Quitline for Lung Cancer (PROACT Trial)

N/A

Waitlist Available

Led By Steven B. Zeliadt, PhD MPH

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0-12 weeks after provider offers patient lung cancer screening

Awards & highlights

PROACT Trial Summary

This trial will evaluate if offering proactive smoking cessation support to smokers as part of participating in lung cancer screening within Veterans Health Administration is effective.

Eligible Conditions

Lung Cancer
Tomography
Lung Disease
Tobacco Smoking
Smoking Cessation
Tobacco Use

PROACT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0-12 weeks after provider offers patient lung cancer screening

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0-12 weeks after provider offers patient lung cancer screening

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-12 weeks after provider offers patient lung cancer screening for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Self-reported smoking abstinence

Secondary outcome measures

Cost of proactive cessation care

Patients' experience with telephone counseling

Patients' motivational assessment

+3 more

PROACT Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Proactive careExperimental Treatment2 Interventions

Providers in this arm will receive guidance from the study team about offering lung cancer screening patients proactive cessation care, including cessation medications and behavioral telephone counseling.

Group II: Unstructured careActive Control1 Intervention

Providers in this arm will continue to provide care as usual during lung cancer screening, with no intervention from the study team.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Proactive Telephone Counseling from VA Quitline

2019

N/A

~830

Unsigned note to provider about cessation medication prescription

2019

N/A

~830

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,612 Previous Clinical Trials

3,304,915 Total Patients Enrolled

Fred Hutchinson Cancer CenterOTHER

557 Previous Clinical Trials

1,342,687 Total Patients Enrolled

Steven B. Zeliadt, PhD MPHPrincipal InvestigatorVA Puget Sound Health Care System Seattle Division, Seattle, WA

1 Previous Clinical Trials

3,726 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly candidates accepted for this clinical research?

"This study is accepting geriatric patients aged between 55 and 80 years old."

Answered by AI

What objectives does this investigation hope to fulfill?

"This 12-month trial will primarily evaluate self-reported smoking abstinence. Secondary goals are to assess patient motivation, efficacy and provider acceptance of proactive cessation care via surveys."

Answered by AI

Is my profile compatible with the parameters of this research program?

"In this medical study, 828 individuals aged 55 to 80 with tomography are sought. Additionally, these participants must have recently undergone a lung cancer screening and still identify as smokers at the time of their appointment."

Answered by AI

Is this research endeavor still open for enrollment?

"Evidently, the clinical trial has ceased seeking participants as per its listing on clinicaltrials.gov; with its first post-date of May 10th 2019 and most recent update happening on November 4th 2022. Nevertheless, there are 1856 other trials that remain actively recruiting at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment

2019. "Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03612804.